SCHEMBL13495352

SCHEMBL13495352

COc1cc2c3c(cccc3c1OC)C(=O)N(OC)C2=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 2/20 0.54
LMNA P02545 2/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 1/20 0.54
PABPC1 P11940 1/20 0.54
XBP1 P17861 1/20 0.54
NFKB1 P19838 1/20 0.54
HTT P42858 1/20 0.54
SMARCA2 P51531 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
PRMT1 Q99873 1/20 0.51
CTSV O60911 2/20 0.45
GAA P10253 2/20 0.41
RECQL P46063 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7712214 0.87 MAPT (0.71) KMT2AKDM4EALDH1A1LMNAPOLB
SCHEMBL13495346 0.82 PRMT1 (0.74) KMT2AKDM4EALDH1A1LMNAPOLB
SCHEMBL7709465 0.78 POLB (0.51) KMT2AKDM4EALDH1A1LMNAPOLB
SCHEMBL12486030 0.77 ALDH1A1 (0.47) KMT2AKDM4EALDH1A1LMNAPOLB
SCHEMBL7709426 0.73 KMT2A (0.68) KMT2AKDM4EALDH1A1LMNAPOLB
SCHEMBL7709844 0.73 KMT2A (0.68) KMT2AKDM4EALDH1A1LMNAPOLB
SCHEMBL28735834 0.73 PRMT1 (0.74) KMT2AKDM4EALDH1A1LMNAPOLB
SCHEMBL13495353 0.73 CYP1B1 (0.63) KMT2AKDM4EALDH1A1LMNAPOLB
SCHEMBL13495358 0.73 KMT2A (0.55) KMT2AKDM4EALDH1A1LMNAPOLB
SCHEMBL13496074 0.72 KMT2A (0.42) KMT2AKDM4EALDH1A1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329377-B2 Imide compound and chemically amplified resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-11 US disclosed
US-20100028807-A1 Imide Compound and Chemically Amplified Resist Composition Containing The Same SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100028807-A1 Imide Compound and Chemically Amplified Resist Composition Containing The Same IGF1R, CCNA1, MYC KMT2A 219/4885KDM4E 1539/4885ALDH1A1 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.